ADK-676АДК-676
What is it?
An experimental adamantane code in the 1996 hepatic-enzyme screen. Original structural records and compound-specific pharmacology require further recovery.
Research context
An experimental adamantane code in the 1996 hepatic-enzyme screen. Original structural records and compound-specific pharmacology require further recovery.
What the studies found
animal · 1996
Mouse hepatic-enzyme screening; 18 adamantane compounds
ADK-559/591/676/677 weakly inhibited hepatic monooxygenase activity. ADK-709/790/828/829/910/918 were identified as P450 inducers. This is an enzyme-screening result, not an endurance or clinical-benefit comparison.
Limit: Original structures and tables require checking against the scan; transcription errors are possible.
Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects ↗Selected findings, not a systematic review or a treatment recommendation. Combination and related-preparation results cannot be attributed to this compound alone. See each source for access status and remaining limitations.
- Working classification
- Archival adamantane screening lead
- Research collection
- Actoprotection & occupational pharmacology · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —No human efficacy findings verified in this update
- Study methods
- —Source-specific animal, chemistry, patent or dissertation evidence
- Independent replication
- —Independent replication not established; translations are not separate experiments
- Source access
- —Access and review depth appear with each linked record
- Safety evidence
- —Human safety and interactions not established; animal activity is not a safe-use recommendation
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Chlodantane, Cyclontane and the ADK research programme ↗
Linked sources
Explore the research map and unresolved leads ↗
Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects
· Dissertation; OCR reproduction
Format: Dissertation abstract transcription · Reviewed: See scope
T. G. Khlopushina · Doctoral dissertation author’s abstract. Moscow, 1996
ADK-559/591/676/677 weakly inhibited hepatic monooxygenase activity. ADK-709/790/828/829/910/918 were identified as P450 inducers. This is an enzyme-screening result, not an endurance or clinical-benefit comparison.
- Population / setting
- Mouse hepatic-enzyme screening; 18 adamantane compounds
- What was checked
- Selected source passages checked; complete methods and risk of bias not appraised.
Limitations & review scope
- Original structures and tables require checking against the scan; transcription errors are possible.
- Enzyme induction does not establish detoxification benefits or predict safe human drug combinations.
Source checked 2026-10-03. This is a source-linked record, not a completed evidence review.